• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Streamex Corp. Highlights Year of Progress, Files Annual Report & Announces Earnings and Corporate Update Presentation

    4/1/26 8:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $STEX alert in real time by email

    WINTER PARK, Fla., April 01, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology and infrastructure company focused on the tokenization of commodity real-world assets, today announced that it has filed its Annual Report Form 10-K and will host an earnings and corporate update presentation on April 8, 2026. The Company also released a 2025 year-in-review and 2026 subsequent events update highlighting a transformative year of execution and platform development.

    Key Highlights from the Past Year

    • Strengthened Board and leadership with several key appointments including Mitch Williams, Kevin Gopaul, Shawn Matthews, Anthony Marciano, Christine Plummer
    • Raised approximately $55M in equity capital resulting in a strong current cash position
    • Eliminated all outstanding debt improving financial flexibility and the ability to fund growth.
    • Launched GLDY, a first of its kind yield-bearing tokenized gold asset



    Morgan Lekstrom, Co-Founder and Executive Chairman stated, "In a short period of time the company transitioned into a tokenized commodities platform, significantly strengthened our balance sheet, and launched GLDY and the Streamex platform. With a very healthy balance sheet, no debt and our first product live, we are now focused on growing GLDY and expanding product offerings into other tokenized commodities."

    Upcoming Earnings and Corporate Update Presentation

    Streamex will host an earnings and corporate update presentation on Wednesday, April 8, 2026, at 4:30pm EST where management will provide updates on financial results, GLDY adoption, product development, and strategic initiatives.

    Investors and interested parties are invited to submit questions ahead of the presentation here:

    Question Submission: https://forms.gle/5ZZYPM36buPXimRP7

    Link for the presentation will be published prior to the date.

    Year in Review

    In May 2025, Streamex completed its share exchange transaction with BioSig Technologies, creating a publicly traded company focused on tokenized commodity real-world assets, and later rebranded to Streamex Corp.

    During the year, the Company strengthened its leadership team and Board of Directors. Mitch Williams joined as Chief Investment Officer, while advisors including Frank Giustra, Sean Roosen, Mathew August, Trevor Bacon and Kellan Grenier supported strategic development. The Board was further expanded with the appointments of Kevin Gopaul, Anthony Marciano and Shawn Matthews. Morgan Lekstrom was appointed Interim Executive Chairman and Christine Plummer joined as Chief Financial Officer.

    Streamex also strengthened its balance sheet, raising $15 million in August 2025 and $40.25 million in January 2026, while repaying its secured convertible debenture and cancelling its standby equity purchase agreement, leaving the Company debt-free with a strong capital position.

    A major milestone for the Company was the launch of GLDY, a yield-bearing gold-backed tokenized security available through the Streamex platform. The Company also established key partnerships with Chainlink and joined the Solana Policy Institute's Project Open initiative, supporting the development of regulated blockchain capital markets.

    Looking Ahead

    With the platform now live, revenue generation underway, and additional products in development, Streamex believes it is entering the next phase of its growth strategy. The Company continues to enhance its platform, expand liquidity solutions for GLDY, and advance its product pipeline and growth of GLDY, including the development of a silver-backed tokenized asset.

    Further updates regarding GLDY growth, liquidity initiatives and AUM expansion are expected in future announcements.

    About Streamex Corp.

    Streamex Corp. (NASDAQ:STEX) is a technology and infrastructure company focused on the tokenization and digitalization of commodity real-world assets. Streamex delivers institutional-grade solutions that bridge traditional finance and blockchain-enabled markets through secure, regulated, and yield-bearing financial instruments.

    For more information, visit www.streamex.com.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements regarding the Company's strategy, future growth, financial position, expected development and expansion of its platform, anticipated growth and adoption of GLDY, potential revenue generation, liquidity initiatives, product development, including the anticipated launch of additional tokenized commodity products, and the Company's expectations regarding opportunities in the tokenized real-world asset ("RWA") market.

    Forward-looking statements are typically identified by words such as "anticipate," "believe," "expect," "intend," "plan," "may," "will," "should," "estimate," "continue," "potential," and similar expressions, although not all forward-looking statements contain these identifying words. These statements are based on current expectations, estimates, and assumptions about the Company's business, the digital asset and commodities markets, and the regulatory environment in which the Company operates.

    Forward-looking statements are subject to risks and uncertainties, many of which are beyond the Company's control, that could cause actual results to differ materially from those expressed or implied by such statements. These risks include, but are not limited to, market conditions, the adoption and development of blockchain and tokenization technologies, regulatory developments affecting digital assets or tokenized securities, the Company's ability to develop and commercialize its products, the availability of liquidity and trading infrastructure for tokenized assets, and other risks described in the Company's filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 10-K and subsequent filings.

    Readers are cautioned not to place undue reliance on forward-looking statements. Except as required by law, Streamex undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

    Contacts

    Streamex Press & Investor Relations

    Adele Carey – Alliance Advisors Investor Relations

    IR@streamex.com | acarey@allianceadvisors.com

    Henry McPhie

    Chief Executive Officer, Streamex Corp.

    www.streamex.com | X.com/streamex



    Primary Logo

    Get the next $STEX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $STEX

    DatePrice TargetRatingAnalyst
    11/25/2025$12.00Buy
    Needham
    More analyst ratings

    $STEX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Streamex Corp. and Orca Announce Launch of 24/7 Decentralized Secondary Liquidity Infrastructure for Tokenized Securities; GLDY the Inaugural Asset

    WINTER PARK, Fla., May 27, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex") (NASDAQ:STEX), a technology company building the tokenization ecosystem for all real-world assets beginning with commodities, today announced the launch of 24/7 secondary liquidity infrastructure for holders to trade tokenized securities, developed in partnership with Orca, a leading automated market maker (AMM) infrastructure provider on the Solana blockchain. Streamex's GLDY, a gold-backed, yield-bearing tokenized security, is the inaugural asset to trade on this infrastructure, in the "GLDY Pool on Orca." This marks a significant milestone for the broader tokenized real-world asset market as a vital piece of

    5/27/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Appoints Former Microsoft and PayPal Lead Product Designer Kori Handy as Vice President of Product and Design

    WINTER PARK, Fla., May 26, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company building the tokenization ecosystem for all real-world assets beginning with commodities, today announced the appointment of Kori Handy as Vice President of Product and Design. Kori brings 18 years of experience scaling fintech and SaaS platforms from zero to $2B+ in assets under management and more than 200 million users, and joins Streamex at a pivotal moment in the Company's growth trajectory. Highlights Kori brings nearly two decades of product, design, and startup leadership experience building fintech and SaaS platforms used by more than 200 million p

    5/26/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Provides Q1 2026 Earnings and Corporate Update Presentation Recap; Highlights New Partnerships & Key Updates

    WINTER PARK, Fla., May 21, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company focused on the tokenization of commodity real-world assets, yesterday hosted its Q1 2026 Earnings and Corporate Update Presentation, featuring remarks from Executive Chairman Morgan Lekstrom, Chief Executive Officer Henry McPhie, Chief Financial Officer Christine Plummer, and Chief Investment Officer Mitch Williams. The following is a summary of the key topics covered. Highlights Equity Trust - access to $72B+ and 359,000 U.S. tax-advantaged retirement accounts. An upcoming integration with Equity Trust Company opens GLDY to a distribution channel that prev

    5/21/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STEX
    SEC Filings

    View All

    Streamex Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Streamex Corp. (0001530766) (Filer)

    5/28/26 4:05:31 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Streamex Corp. (0001530766) (Filer)

    5/27/26 6:05:10 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 10-Q filed by Streamex Corp.

    10-Q - Streamex Corp. (0001530766) (Filer)

    5/14/26 5:24:55 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STEX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Interim Executive Chairman Lekstrom Morgan Lee bought $147,289 worth of shares (47,000 units at $3.13) (SEC Form 4)

    4/A - Streamex Corp. (0001530766) (Issuer)

    5/28/26 9:43:32 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Interim Executive Chairman Lekstrom Morgan Lee bought $49,980 worth of shares (34,000 units at $1.47) (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    5/28/26 2:33:28 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Marciano Anthony Mark bought $20,052 worth of shares (17,745 units at $1.13), increasing direct ownership by 18% to 117,745 units (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    5/22/26 4:05:25 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STEX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Investment Officer Williams Mitchell Young sold $24,915 worth of shares (23,810 units at $1.05), decreasing direct ownership by 0.78% to 3,013,838 units (SEC Form 4) to satisfy withholding obligation

    4 - Streamex Corp. (0001530766) (Issuer)

    6/2/26 9:54:16 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amendment: SEC Form 4 filed by Interim Executive Chairman Lekstrom Morgan Lee

    4/A - Streamex Corp. (0001530766) (Issuer)

    5/28/26 9:44:06 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amendment: Interim Executive Chairman Lekstrom Morgan Lee bought $147,289 worth of shares (47,000 units at $3.13) (SEC Form 4)

    4/A - Streamex Corp. (0001530766) (Issuer)

    5/28/26 9:43:32 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STEX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Needham initiated coverage on Streamex Exchange Corporation with a new price target

    Needham initiated coverage of Streamex Exchange Corporation with a rating of Buy and set a new price target of $12.00

    11/25/25 7:59:34 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STEX
    Leadership Updates

    Live Leadership Updates

    View All

    Streamex Corp. Appoints Former Microsoft and PayPal Lead Product Designer Kori Handy as Vice President of Product and Design

    WINTER PARK, Fla., May 26, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company building the tokenization ecosystem for all real-world assets beginning with commodities, today announced the appointment of Kori Handy as Vice President of Product and Design. Kori brings 18 years of experience scaling fintech and SaaS platforms from zero to $2B+ in assets under management and more than 200 million users, and joins Streamex at a pivotal moment in the Company's growth trajectory. Highlights Kori brings nearly two decades of product, design, and startup leadership experience building fintech and SaaS platforms used by more than 200 million p

    5/26/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Appoints Christine Plummer, Former Global Controller at Coinbase and Managing Director at Morgan Stanley, as Chief Financial Officer

    WINTER PARK, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology and infrastructure company focused on the tokenization of commodity real-world assets, today announced the appointment of Christine Plummer, former Global Controller at Coinbase and Managing Director at Morgan Stanley, as Chief Financial Officer of Streamex. In this role, Ms. Plummer is expected to oversee the Company's global finance organization, including financial reporting, regulatory compliance, and financial operations as Streamex continues expanding its institutional platform and launching tokenized commodity products. Henry McPhie, Co-Founder & CEO of Str

    3/16/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Appoints Shawn Matthews, Former CEO of Cantor Fitzgerald & Co. & Founder and CIO of Hondius Capital Management, to Board of Directors

    WINTER PARK, Fla., March 03, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a leader in institutional-grade tokenization and digital asset infrastructure, today is excited to announce the appointment of Shawn Matthews, Former CEO of Cantor Fitzgerald & Co. and Founder and Chief Investment Officer of Hondius Capital Management, to its Board of Directors. In this role, Mr. Matthews will bring decades of global investment, trading, and executive leadership experience to support Streamex's strategic growth, capital markets initiatives, and governance. He is joining as an independent director. Morgan Lekstrom, Co-Founder & Executive Chairman of Streamex sa

    3/3/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STEX
    Financials

    Live finance-specific insights

    View All

    Streamex Corp. Provides Q1 2026 Earnings and Corporate Update Presentation Recap; Highlights New Partnerships & Key Updates

    WINTER PARK, Fla., May 21, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company focused on the tokenization of commodity real-world assets, yesterday hosted its Q1 2026 Earnings and Corporate Update Presentation, featuring remarks from Executive Chairman Morgan Lekstrom, Chief Executive Officer Henry McPhie, Chief Financial Officer Christine Plummer, and Chief Investment Officer Mitch Williams. The following is a summary of the key topics covered. Highlights Equity Trust - access to $72B+ and 359,000 U.S. tax-advantaged retirement accounts. An upcoming integration with Equity Trust Company opens GLDY to a distribution channel that prev

    5/21/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Announces April 2026 Yield Dividend Distribution for GLDY

    WINTER PARK, Fla., May 18, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company focused on the tokenization of commodity real-world assets, today announced the distribution of the second yield payment for GLDY, its gold-backed, yield-bearing tokenized security. The distribution covers the period from April 1st through April 30th, 2026. Yield Distribution Details GLDY's real-world yield is generated through Streamex's institutional gold leasing program, with proceeds from the program distributed to GLDY holders in the form of additional GLDY tokens monthly. Gold on lease is currently earning an annualized lease yield of 3.5%. For the mo

    5/18/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Reports Q1 2026 Financial Results and Announces Business & Quarterly Update Call

    WINTER PARK, Fla., May 14, 2026 (GLOBE NEWSWIRE) --  Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company focused on the tokenization of commodity real-world assets, today announced that it has filed its Q1 2026 financial results and will host an earnings and corporate update presentation on Wednesday, May 20, 2026, at 4:30 p.m. ET. Henry McPhie, Co-Founder & Chief Executive Officer of Streamex, said: "Q1 2026 was a transformative quarter for Streamex. We raised over $40 million in equity capital, fully deleveraged our balance sheet, and launched GLDY. We made our first yield distribution to GLDY holders, paying investors in gold to hold gold for the first tim

    5/14/26 6:01:22 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care